Century Therapeutics, Inc. earnings per share and revenue

IPSC earnings per share for the last quarter are -0.37 USD whereas the estimation was -0.45 USD which accounts for 17.91% surprise. Company revenue for the same period amounts to 791.00 k USD despite the estimated figure of 440.00 k USD. Estimated earnings per share for the next quarter are -0.41 USD, and revenue is expected to reach 784.43 k USD. Also watch annual changes over time to get a bigger picture of IPSC earnings per share and revenue dynamics.